![]() |
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vol. 287, Issue 3, 969-974, December 1998
Neuroimmunology Laboratory (P.G., C.M., S.S.), Istituto di Ricerche
Farmacologiche Mario Negri, Milano, Italy;
Consorzio Biolaq (S.P.),
L'Aquila, Italy; and
Department of Pharmacology (G.M., L.P., C.A.,
A.M., V.S., G.C., R.B.), Dompé S.p.A. Research Center, L'Aquila,
Italy
Among nonsteroidal anti-inflammatory drugs (NSAIDs), 2-arylpropionic
acids exist as a racemic mixture of its enantiomeric forms, with
S-enantiomers primarily responsible for inhibition of
prostaglandin synthesis and of inflammatory events. The aim of this
study was to compare the anti-inflammatory effects of R- and
S-ketoprofen in vitro and in vivo.
S-Ketoprofen efficiently inhibited carrageenan-induced edema
formation, but it could also amplify the LPS-induced production of the
inflammatory cytokines tumor necrosis factor (TNF) and interleukin-1
(IL-1), in close correlation with its ability to inhibit prostaglandin
synthesis. Because these inflammatory cytokines are among the factors
involved in carrageenan-induced inflammation and also are possibly
involved in gastric damage, enhanced cytokine production could
partially mask the analgesic effect of S-ketoprofen, and it
can be associated with the clinical evidence of its gastric toxicity.
On the other hand, R-ketoprofen contributes to the overall
activity of the racemate, by playing the main role in
ketoprofen-induced analgesia. Unlike the S-isomer,
R-ketoprofen did not induce a significant increase of
cytokine production even at cyclooxygenase-blocking concentrations. It
is concluded that the R-isomer directly contributes to the
anti-inflammatory effects of ketoprofen, being more analgesic, and
because it does not amplify inflammatory cytokine production.